CAR-T therapy sets new milestone in neuroblastoma treatment
New research shows that GD2 CAR-T cell therapy offers a potential cure for neuroblastoma, with some patients achieving long-term remission for over a decade—marking a major milestone in solid tumor treatment. Study: Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma. Image Credit: ART-ur / Shutterstock.com In a recent study published in Nature Medicine, … Read more